Garofalo Health Care S.p.A
Garofalo Health Care S.p.A., together with its subsidiaries, operates healthcare clinics in Italy. It operates through Hospital and Social/Dependency Care segments. The company offers high-complexity surgery, medium- and low-complexity surgery, emergency surgery, medicine, clinical and interventional cardiology, and extended and intensive care units, as well as motor, neurological, cardiac, and n… Read more
Market Cap & Net Worth: Garofalo Health Care S.p.A (GHC)
Garofalo Health Care S.p.A (F:GHC) has a market capitalization of $419.80 Million (€408.98 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #17226 globally and #1795 in its home market, demonstrating a -9.92% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Garofalo Health Care S.p.A's stock price €4.63 by its total outstanding shares 88332234 (88.33 Million).
Garofalo Health Care S.p.A Market Cap History: 2018 to 2026
Garofalo Health Care S.p.A's market capitalization history from 2018 to 2026. Data shows growth from $325.05 Million to $419.80 Million (3.68% CAGR).
Garofalo Health Care S.p.A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Garofalo Health Care S.p.A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.04x
Garofalo Health Care S.p.A's market cap is 1.04 times its annual revenue
0.38x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
22.40x
Garofalo Health Care S.p.A's market cap is 22.40 times its annual earnings
6.36x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $325.05 Million | $154.43 Million | $13.58 Million | 2.10x | 23.93x |
| 2019 | $526.80 Million | $196.10 Million | $13.14 Million | 2.69x | 40.08x |
| 2020 | $478.74 Million | $206.78 Million | $11.78 Million | 2.32x | 40.64x |
| 2021 | $493.25 Million | $277.87 Million | $18.83 Million | 1.78x | 26.19x |
| 2022 | $327.77 Million | $314.76 Million | $21.43 Million | 1.04x | 15.30x |
| 2023 | $414.36 Million | $366.13 Million | $20.80 Million | 1.13x | 19.92x |
| 2024 | $485.99 Million | $467.77 Million | $21.70 Million | 1.04x | 22.40x |
Competitor Companies of GHC by Market Capitalization
Companies near Garofalo Health Care S.p.A in the global market cap rankings as of March 18, 2026.
Key companies related to Garofalo Health Care S.p.A by market ranking:
- HCA Holdings Inc (NYSE:HCA): Ranked #271 globally with a market cap of $77.08 Billion USD.
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1068 globally with a market cap of $18.32 Billion USD.
- Fresenius SE & Co. KGaA (PINK:FSNUF): Ranked #1139 globally with a market cap of $16.86 Billion USD.
- Brookdale Senior Living Inc (NYSE:BKDT): Ranked #1227 globally with a market cap of $15.19 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #271 | HCA Holdings Inc | NYSE:HCA | $77.08 Billion | $509.87 |
| #1068 | Tenet Healthcare Corporation | NYSE:THC | $18.32 Billion | $211.64 |
| #1139 | Fresenius SE & Co. KGaA | PINK:FSNUF | $16.86 Billion | $41.01 |
| #1227 | Brookdale Senior Living Inc | NYSE:BKDT | $15.19 Billion | $77.60 |
Garofalo Health Care S.p.A Historical Marketcap From 2018 to 2026
Between 2018 and today, Garofalo Health Care S.p.A's market cap moved from $325.05 Million to $ 419.80 Million, with a yearly change of 3.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €419.80 Million | -15.20% |
| 2025 | €495.06 Million | +1.87% |
| 2024 | €485.99 Million | +17.29% |
| 2023 | €414.36 Million | +26.42% |
| 2022 | €327.77 Million | -33.55% |
| 2021 | €493.25 Million | +3.03% |
| 2020 | €478.74 Million | -9.12% |
| 2019 | €526.80 Million | +62.06% |
| 2018 | €325.05 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Garofalo Health Care S.p.A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $419.80 Million USD |
| MoneyControl | $419.80 Million USD |
| MarketWatch | $419.80 Million USD |
| marketcap.company | $419.80 Million USD |
| Reuters | $419.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.